Long-term Prognosis & Impact of Osgood Schlatter

Catherine Logan

September 7th, 2020

Long-term Prognosis and Impact of Osgood Schlatter Disease 4 Years After Diagnosis: A Retrospective Study.
SourceOJSM, first published October 31, 2019

Clinical Question: What is the prognosis 2 to 6 years after the diagnosis of OSD?

Bottom Line: Symptoms persisted in 60%. The median symptom duration was 90 months for those still experiencing knee pain, and 42.9% of these reported daily knee pain.
Points to Consider: This is a level 3, cohort study. Of the 84 patients, only 43 responded. Of these, 60.5% (n=26) reported OSD related knee pain at median follow-up of 3.75 years. 54% with knee pain had reduced their sports participation compared with 35.3% of those without knee pain. 
Takeaway: This study indicates that OSD may not be as self-limiting as we think. Additionally, the lower self-reported function and health related quality of life scores in those with continued pain may be a consequence of impaired physical activity due to knee pain. These patients need follow-up to ensure they are on track for improvement.

About the Author:
Catherine A. Logan, MD, MBA, MSPT is a sports medicine Orthopaedic Surgeon and writer. Based in Denver, CO, she is an attending at Colorado Sports Medicine & Orthopaedics at Rose Medical Center. Dr. Logan is the Head League Physician for Premier Lacrosse League (PLL) member of the team physician pool for the US Ski & Snowboard teams each year. Dr. Logan completed her Orthopaedic Surgery residency at the Harvard Combined Orthopaedic Residency Program and her Sports Medicine Fellowship training at the prestigious Steadman Philippon Research Institute/The Steadman Clinic in Vail, CO. Logan is also on the board of The Chill Foundation.